Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Candela

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
American Heart Journal|August 1, 1989
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortalityE R Bates, R M Califf, R S Stack, et al.
Circulation|May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
Journal of the American College of Cardiology|February 1, 1991
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD J Kereiakes, E J Topol, B S George, et al.
Circulation|February 1, 1989
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
Journal of the American College of Cardiology|October 1, 1990
Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplastyC W Abbottsmith, E J Topol, B S George, et al.
American Heart Journal|March 1, 1991
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupE M Ohman, R M Califf, B S George, et al.
The New England Journal of Medicine|September 3, 1987
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
American Heart Journal|August 1, 1989
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortalityE R Bates, R M Califf, R S Stack, et al.
Circulation|May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
Journal of the American College of Cardiology|February 1, 1991
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD J Kereiakes, E J Topol, B S George, et al.
Circulation|February 1, 1989
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
Journal of the American College of Cardiology|October 1, 1990
Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplastyC W Abbottsmith, E J Topol, B S George, et al.
American Heart Journal|March 1, 1991
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupE M Ohman, R M Califf, B S George, et al.
The New England Journal of Medicine|September 3, 1987
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
Pageof 5